The CBD (cannabidiol) market is surging, moving out of the shadows and into mainstream retail. Big-name drug retailers CVS and Walgreens have announced they will carry the nonintoxicating CBD products, and industry analysts predict the market could hit $22 billion in sales by 2022.
Is CBD a new category for convenience, and will it help shore up declines in tobacco and fuel? Learn answers to those questions as we explore the legal and regulatory hurdles and hear what it will take to develop this new category in your stores. In an exclusive fireside chat, Bonnie Herzog, managing director of equity research for Wells Fargo, and Brent Johnson, chief executive officer, Hoban Law Group, a law firm versant in the area of CBD and cannabis, explore CBD's potential in the brick-and-mortar space.